Conventional (and not-so-conventional) Treatments for Idiopathic Hypersomnia
Channel: Hypersomnia Foundation
Date: 2019-08-02

2018 June – Lynn Marie Trotti, MD, MSc, HF Medical Advisory Board Chair, Associate Professor of Neurology at Emory University  - “Conventional (and not-so-conventional) Treatments for Idiopathic Hypersomnia”

Dr. Trotti discusses conventional IH treatments of modafinil, armodafinil, and various stimulants as well as the not-so-conventional treatments of sodium oxybate, clarithromycin, compounded flumazenil, Levothyroxine, and transcranial direct current stimulation.

Since the recording of this presentation, a medication called solriamfetol has been approved by the FDA for the treatment of narcolepsy and sleep apnea. At this time, there does not seem to be any data testing solriamfetol use in IH, but in the future it may be used as a treatment for people with refractory IH (IH that is not helped by any of the current treatments).

Get the PPP slides and all our videos and podcasts here: https://www.hypersomniafoundation.org/videos/.

In October, 2019, HF completely updated the "Treatments" page of our website: https://www.hypersomniafoundation.org/about-treatment/.

If this video is helpful to you, please consider donating to HF. Your donation makes these resources possible! https://www.hypersomniafoundation.org/donate.